Dec 11 (Reuters) - The U.S. Food and Drug Administration has approved Flow Neuroscience's at-home brain stimulation device to treat depression, offering an alternative to typical antidepressants that ...

The FDA has approved its first at-home, nondrug therapy for depression, with a wearable brain stimulation headset developed by Flow Neuroscience. The agency issued a green light that covers the device ...

A controversy is swirling at a Texas university. The trigger? A flowchart. On Dec. 1, the new chancellor of the Texas Tech University system sent professors a diagram laying out a chain of approval ...

Attention! Another new term has entered the TikTok lexicon, and you’re about to see it everywhere. If you’ve spent any time on the app within the past week, you might have noticed people talking about ...

Bengaluru: Meesho has pulled ahead of its consumer internet peers on free cash flow in FY25, underscoring a shift in India’s e-commerce sector from chasing growth to focusing on capital-efficient ...

Stock market graphs don’t have to be a mystery. Here’s how to read stock charts for any company. Many, or all, of the products featured on this page are from our advertising partners who compensate us ...

A recent study revealed that almost 90% of stock market traders experience financial losses during their trading journeys. This statistic highlights the challenges and inherent risks associated with ...

Stream 'Flow (2024)' and watch online. Discover streaming options, rental services, and purchase links for this movie on Moviefone. Watch at home and immerse yourself in this movie's story anytime.

Andrew Kessel was a breaking news writer for Investopedia until October 2025. He previously covered markets for Proactive Investors, with a focus on small-cap stocks in fintech, healthcare, mining, ...

DALLAS--(BUSINESS WIRE)--Flowserve Corporation (NYSE: FLS) (“Flowserve”), a leading provider of flow control products and services for the global infrastructure markets, today announced it has ...

Chart Industries (NYSE:GTLS) +17.1% post-market Monday after the Financial Times reported Baker Hughes (NASDAQ:BKR) is near a $13.6B cash deal to acquire the company, valuing Chart at $210/share, a 22 ...